Computer Engineering Elevates Oncology Treatment Safety with the Launch of Chimio Version 6.0 and MobiChimio

The landscape of hospital pharmacy management and oncology care is undergoing a profound digital transformation, driven by the continuous imperative to eliminate medication errors and safeguard vulnerable patients. Computer Engineering, a recognized specialist in healthcare software solutions, has officially rolled out version 6.0 of its flagship application, Chimio. Widely adopted by hospital pharmacists for its extensive parametrization capabilities and operational flexibility, the new software iteration introduces critical advancements designed to fortify the entire chemotherapy medication pathway. By transitioning from traditional paper-based manufacturing sheets to a fully paperless workflow and introducing an optional mobile module tailored for bedside care, Computer Engineering is setting a new benchmark in clinical safety, process traceability, and patient identification.

The Evolution of Oncology Software: Background and Context

Chemotherapy preparation and administration represent some of the most complex, high-risk procedures in modern clinical practice. The margin for error is exceptionally narrow, as cytotoxic drugs require precise dosing tailored strictly to individual patient biometrics, tumor types, and treatment protocols. Historically, hospital pharmacies relied heavily on manual, paper-based tracking systems to manage prescriptions, preparation steps, and final product releases. While functional, these legacy systems carried inherent risks associated with human error, illegible handwriting, missed verification steps, and cumbersome physical archiving.

Over the past decade, the digitization of healthcare has sought to address these vulnerabilities. Computer Engineering has been at the forefront of this movement, developing software that bridges the gap between the medical prescription and the bedside administration. The release of Chimio version 6.0 is the culmination of years of continuous feedback from oncology pharmacists, pharmacy technicians, and nursing staff. By observing the daily operational bottlenecks and safety challenges faced by healthcare professionals on hospital floors, the development team engineered a comprehensive solution that eliminates paper entirely from the preparation phase while extending digital verification directly into the hands of nurses administering the treatment.

Comprehensive Control and Digitalization in the Preparation Phase

At the core of Chimio version 6.0 is the complete elimination of paper manufacturing sheets, replaced by an integrated, digitized workflow available as a standard feature. This digital transformation covers every critical stage of the process, from the initial evaluation of the physician’s prescription to the final release of the chemotherapy bags by the pharmacy team.

According to Vincent Hourdequin, Director of Computer Engineering, the new system fundamentally changes how pharmacy technicians operate in the cleanroom environment. The software guides technicians step-by-step through each stage of the pouch manufacturing process directly on-screen, ensuring that every protocol is rigorously followed without deviation.

"The preparer is guided on-screen for each stage of the pouch manufacturing process, and we have integrated enhanced capabilities to ensure that the correct product is used at the exact right dose," explains Vincent Hourdequin. "We have also significantly reinforced the control checkpoints throughout the workflow."

Concretely, this dematerialized approach translates into several sophisticated technological safeguards:

• Standardized Process Definition: The software outlines exact step-by-step procedures, providing real-time on-screen guidance to technicians to prevent skipped actions or procedural oversights.
• Advanced Barcode and Gravimetric Security: Integration of Datamatrix code scanning, customizable digital check-lists, mandatory gravimetric controls to verify weight and density accuracy, and integrated photographic documentation of the preparation.
• Tray and Release Management: Streamlined preparation of workflow trays, paired with high-visibility dashboard displays for pharmacists during the final pharmaceutical release phase.

These rigorous controls ensure a seamless match between the prepared chemotherapy bag, the specific patient profile, and the oncologist’s original prescription, dramatically reducing the risk of compounding errors before the drugs ever leave the hospital pharmacy.

Extending Safety to the Bedside with MobiChimio

While securing the pharmacy preparation phase is paramount, patient safety remains equally vulnerable during the final administration stage. Recognizing this operational reality, Computer Engineering expanded its technological ecosystem beyond the pharmacy walls. By closely studying nursing workflows in active clinical environments, the company developed mobiChimio, a specialized mobile application designed to operate on pocket-sized, ruggedized mobile terminals.

Deployed on lightweight, ergonomic devices equipped with integrated barcode scanners and secure Wi-Fi connectivity to the hospital’s core network, mobiChimio acts as a direct bridge between the bedside and the central pharmacy database. Its primary objective is to eradicate patient misidentification—a persistent challenge in busy oncology units—by elevating identity verification standards through robust identitovigilance protocols.

Throughout the administration process, healthcare professionals use the mobile terminal to scan barcodes and Datamatrix labels. This multi-point scanning verifies the identity of the healthcare provider via a scanned staff badge, confirms the identity of the patient via a barcode-enabled wristband displaying the Permanent Patient Identifier (IPP) or hospital stay number, and authenticates the specific chemotherapy bag.

Real-World Implementation: The Day Hospital Model

The efficacy of mobiChimio is particularly evident in high-throughput ambulatory settings, such as day hospitals where patient turnover is rapid and continuous. A notable early adopter of this technology is the West Cancer Institute (Institut de Cancérologie de l’Ouest) located in Angers, France.

In these fast-paced clinical environments, nursing teams utilize mobiChimio to perform instantaneous identity checks by scanning patient wristband labels immediately prior to infusion. The system instantly correlates this patient data with the barcode on the chemotherapy preparation, verifying the dispensary order number and the precise administration sequence.

This final pre-administration check guarantees absolute concordance between the patient and the therapeutic product just seconds before the infusion begins. Furthermore, it automates the traceability of drug administration, feeding real-time updates back into the central Chimio database. Any modifications to prescriptions or updates regarding administered doses are synchronized instantly across the hospital network, ensuring that medical and pharmacy teams maintain complete, up-to-date visibility of the patient’s treatment trajectory.

Implications and Future Outlook for Hospital Oncology

The rollout of Chimio version 6.0 and the mobiChimio module arrives at a critical juncture for European healthcare institutions. Hospitals face mounting pressure to optimize operational efficiency while simultaneously meeting increasingly stringent regulatory standards regarding patient safety and medication traceability.

From a broader economic and institutional perspective, the adoption of fully digital oncology workflows yields significant long-term benefits. By preventing medication errors before compounding and intercepting administration discrepancies at the bedside, hospitals can mitigate the immense clinical, psychological, and financial costs associated with adverse drug events. Furthermore, the automation of documentation and audit trails reduces the administrative burden on clinical staff, allowing pharmacists and nurses to dedicate more time to direct patient care and clinical oversight.

Vincent Hourdequin underscores the overarching philosophy guiding these technological innovations. "With these mobile solutions, our goal is to provide care teams with tools that guarantee secure, unhindered access to patient data wherever they are," he states.

As more healthcare institutions follow the lead of centers like the West Cancer Institute by integrating Chimio 6.0 and mobiChimio into their daily operations, Computer Engineering continues to solidify its reputation as a pioneer in medical software engineering. By seamlessly uniting pharmacy preparation and bedside administration under a single, secure digital umbrella, the company is helping to shape a safer, more transparent, and highly resilient future for oncology care.